Security key
61559X104
MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)
CUSIP: 61559X104
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Class A ordinary share, par value $0.0001 per share
- Shares outstanding
- 71,686,928
- Total 13F shares
- 56,057,516
- Share change
- +16,638,367
- Total reported value
- $2,858,934,462
- Price per share
- $51.00
- Number of holders
- 82
- Value change
- +$861,230,424
- Number of buys
- 71
- Number of sells
- 15
Report period
Q2 2023
Institutions
82
Top holders
10
MLTX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
MoonLake Immunotherapeutics SEC filings
MoonLake Immunotherapeutics company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61559X104
Recent filing periods:
Top shareholders of MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
30%
|
21,751,284
|
$465,259,965 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
9.6%
|
6,892,101
|
$147,422,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.1%
|
2,923,438
|
$62,532,339 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
1,668,871
|
$35,697,151 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.2%
|
876,377
|
$18,745,704 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
830,906
|
$17,774,000 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.1%
|
804,499
|
$17,208,234 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.7%
|
500,000
|
$10,695,000 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.66%
|
475,432
|
$10,169,490 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
303,222
|
$6,486,000 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.42%
|
301,354
|
$6,445,962 | — | 31 Mar 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.39%
|
278,334
|
$5,953,564 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.28%
|
197,707
|
$4,228,953 | — | 31 Mar 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.27%
|
195,000
|
$4,171,000 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
176,770
|
$3,781,110 | — | 31 Mar 2023 | |
| HighVista Strategies LLC |
13F
|
Company |
0.17%
|
122,201
|
$2,613,879 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.16%
|
114,930
|
$2,458,353 | — | 31 Mar 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
106,920
|
$2,287,019 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
105,750
|
$2,261,993 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
77,276
|
$1,652,934 | — | 31 Mar 2023 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.1%
|
73,637
|
$1,575,095 | — | 31 Mar 2023 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.1%
|
72,850
|
$1,558,262 | — | 31 Mar 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.1%
|
69,713
|
$1,491,161 | — | 31 Mar 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
67,312
|
$1,439,804 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
59,858
|
$1,280,363 | — | 31 Mar 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.07%
|
48,550
|
$1,038,485 | — | 31 Mar 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.05%
|
38,856
|
$831,130 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.05%
|
37,200
|
$795,707 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
35,071
|
$750,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
32,519
|
$695,582 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.04%
|
29,748
|
$636,310 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
26,034
|
$556,867 | — | 31 Mar 2023 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.03%
|
23,400
|
$500,526 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
22,700
|
$486,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
17,109
|
$365,961 | — | 31 Mar 2023 | |
| SVB FINANCIAL GROUP |
13F
|
Company |
0.02%
|
16,173
|
$345,940 | — | 31 Mar 2023 | |
| BOULDER HILL CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
14,500
|
$310,155 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.02%
|
11,575
|
$247,589 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,280
|
$219,889 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,960
|
$170,265 | — | 31 Mar 2023 | |
| Dorsey Wright & Associates |
13F
|
Company |
0%
|
1,000
|
$21,390 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
656
|
$14,000 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
76
|
$1,623 | — | 31 Mar 2023 | |
| Helix Holdings LLC |
3/4/5
|
Former 10% Holder |
—
class O/S missing
|
3,215,000
|
$192,569,820 | — | 05 Apr 2022 |
Institutional Holders of MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) as of Q2 2023
As of 30 Jun 2023,
MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,057,516 shares.
The largest 10 holders included
BVF INC/IL, Cormorant Asset Management, LP, FMR LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, Polar Capital Holdings Plc, ADAGE CAPITAL PARTNERS GP, L.L.C., FEDERATED HERMES, INC., and T. Rowe Price Investment Management, Inc..
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
43
Q2 2023 holders
82
Holder diff
39
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.